Korea / Special Situations, Clepsydra Capital

Sanghyun Park

Korea / Special Situations

Event-Driven

Celltrion finally gives us a three-way merger plan in a regulatory filing.Below is the link to the regulatory filing published at DART last Friday after the market closed.<a href="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200925800449" target="_blank" rel="noopener">http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200925800449</a>The filing is brief and straightforward.<ul>
<li>First, there will be a new company named Celltrion Healthcare Holdings. Then, Seo Jung-jin, Founder, will invest his stake of Healthcare into this entity through in-kind investment.</li>
<li>Second, they will merge Celltrion Holdings and Celltrion Healthcare Holdings. The deadline for this merger is December 31, 2021.</li>
<li>Lastly, there will be another merger between Celltrion, Celltrion Healthcare, and Celltrion Pharm. * But the deadline is yet to be announced. Also, the merger mechanism is subject to change depending on the outcome of each company's board and shareholder meeting.
</li>
</ul><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/161/915/original/1.png?1601171221" class="editor-image img-responsive" data-smartkarma-image-id="161915"></figure><div class="content-caption">(Source: DART)</div>

Celltrion finally gives us a three-way merger plan in a regulatory filing.Below is the link to the regulatory filing published at DART last Friday after the market closed.http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200925800449The filing is brief and straightforward.
First, there will be a new company named Celltrion Healthcare Holdings. Then, Seo Jung-jin, Founder, will invest his stake of Healthcare into this entity through in-kind investment.
Second, they will merge Celltrion Holdings and Celltrion Healthcare Holdings. The deadline for this merger is December 31, 2021.
Lastly, there will be another merger between Celltrion, Celltrion Healthcare, and Celltrion Pharm. * But the deadline is yet to be announced. Also, the merger mechanism is subject to change depending on the outcome of each company's board and shareholder meeting.

(Source: DART)

Celltrion Merger Announcement: Details, Questionable Aspects, & Trading Dynamics

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Last Week in Event SPACE: Vedanta, Evergrande Auto, Cocokara, Leyou, Mitsu Lease/Hitachi Cap

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

<div class="content-highlight">
After the market close today, there was a major announcement in the healthcare sector in Korea. <a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a>, <a href="https://www.smartkarma.com/entities/celltrion-healthcare" target="_blank" data-smartkarma-citation="entities:23641:1" rel="noopener">Celltrion Healthcare (091990 KS)</a>, and <a href="https://www.smartkarma.com/entities/celltrion-pharm-inc" target="_blank" data-smartkarma-citation="entities:992:1" rel="noopener">Celltrion Pharm (068760 KS)</a> will be MERGED into one company. Plus, a NEWCO called Celltrion Healthcare Holdings is established.
Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not likely to be overly significant since early this year, the Celltrion Group Chairman Seo Jung-Jin already hinted that there could be a merger among these three companies.
One of the main reasons why the Celltrion Group stocks have done well so far this year has been due to the expectation of the formal merger announcement. As a result, there could be some investors that may actually try to sell the three Celltrion Group related stocks on this news in the near-term. 
</div>


After the market close today, there was a major announcement in the healthcare sector in Korea. Celltrion Inc (068270 KS), Celltrion Healthcare (091990 KS), and Celltrion Pharm (068760 KS) will be MERGED into one company. Plus, a NEWCO called Celltrion Healthcare Holdings is established.
Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not likely to be overly significant since early this year, the Celltrion Group Chairman Seo Jung-Jin already hinted that there could be a merger among these three companies.
One of the main reasons why the Celltrion Group stocks have done well so far this year has been due to the expectation of the formal merger announcement. As a result, there could be some investors that may actually try to sell the three Celltrion Group related stocks on this news in the near-term. 


A Merger of Three Celltrion Group Companies + Formation of a Celltrion Healthcare Holdings

Founder/CEO of ROK Advisory, ROK Advisory LLC

Ken S. Kim

Founder/CEO of ROK Advisory

ROK Advisory LLC

ROK is an independent research advisory firm. We guide you to minimize the information gap between foreign and local investors in Northeast Asia with a focus in Korea, Taiwan and Japan.

Independent Research Advisory Firm

The key seems what happens to the value of Celltrion Holdings and in fact, the merger might not include Celltrion Inc.   The consensus belief is <a href="https://www.smartkarma.com/entities/celltrion-healthcare" target="_blank" data-smartkarma-citation="entities:23641:1" rel="noopener">Celltrion Healthcare (091990 KS)</a> and <a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a> and <a href="https://www.smartkarma.com/entities/celltrion-pharm-inc" target="_blank" data-smartkarma-citation="entities:992:1" rel="noopener">Celltrion Pharm (068760 KS)</a> merge.  Might want to remember what happened with <a href="https://www.smartkarma.com/entities/samsung-c-t-corporation" target="_blank" data-smartkarma-citation="entities:481:1" rel="noopener">Samsung C&amp;T (028260 KS)</a> and Everland to see the blueprint.   I expect a <a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a> stock split and <a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a> and <a href="https://www.smartkarma.com/entities/celltrion-pharm-inc" target="_blank" data-smartkarma-citation="entities:992:1" rel="noopener">Celltrion Pharm (068760 KS)</a> to merge first.

The key seems what happens to the value of Celltrion Holdings and in fact, the merger might not include Celltrion Inc.   The consensus belief is Celltrion Healthcare (091990 KS) and Celltrion Inc (068270 KS) and Celltrion Pharm (068760 KS) merge.  Might want to remember what happened with Samsung C&amp;T (028260 KS) and Everland to see the blueprint.   I expect a Celltrion Inc (068270 KS) stock split and Celltrion Inc (068270 KS) and Celltrion Pharm (068760 KS) to merge first. 

It is now official that Korea's shorting restrictions will get a six-month extension until March 15, 2021.<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/155/975/original/1.png?1598824455" class="editor-image img-responsive" data-smartkarma-image-id="155975"></figure>But the KSC is stressing that the shorting ban is a temporary measure. It says that it will try to resume short trading after this six-month extension.The KSC also says that it will review the cons/pros of the current market maker system, which is one of the exceptions that can short trade under the ongoing shorting restrictions.

It is now official that Korea's shorting restrictions will get a six-month extension until March 15, 2021.But the KSC is stressing that the shorting ban is a temporary measure. It says that it will try to resume short trading after this six-month extension.The KSC also says that it will review the cons/pros of the current market maker system, which is one of the exceptions that can short trade under the ongoing shorting restrictions.

Shorting Restriction Extension: Prolonged Arb Trade Opportunity on KOSDAQ 150 ETFs

South Korea

Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Celltrion Healthcare (091990 KS)

Celltrion Merger Announcement: Details, Questionable Aspects, & Trading Dynamics

Celltrion finally ga

Sanghyun Park

Last Week in Event SPACE: Vedanta, Evergrande Auto, Cocokara, Leyou, Mitsu Lease/Hitachi Cap

Last Week in Event SPACE ... Plus, other events, CCASS movements and Mood Spins. (This insight covers specific insights & comments...

David Blennerhassett

A Merger of Three Celltrion Group Companies + Formation of a Celltrion Healthcare Holdings

Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not...

Douglas Kim

How Might a Celltrion Merger Look?

The key seems what happens to the value of Celltrion Holdings and in fact, the merger might not include Celltrion Inc. The consensus belief is...

Ken S. Kim

Shorting Restriction Extension: Prolonged Arb Trade Opportunity on KOSDAQ 150 ETFs

It is now official that Korea's shorting restrictions will get a six-month extension until March 15, 2021.But the KSC is stressing that the...

Sanghyun Park

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)